Gene · 79577
Papers1,751
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,751
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biting off more than you can chew: a rare case of hyperparathyroidism jaw tumour syndrome. | Oxf Med Case Reports | 2025 | 39839692 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR Activation Is Associated With Malignant Severity and Poorer Prognosis in Parathyroid Carcinomas. | J Clin Endocrinol Metab | 2025 | 39829129 | PubTator, text mining | PubMed |
| Chapter 5: The roles of genetics in primary hyperparathyroidism. | Ann Endocrinol (Paris) | 2025 | 39818301 | PubTator, text mining | PubMed |
| Chapter 8: Management of aggressive forms of primary HPT: Parathyroid carcinoma and atypical parathyroid tumor. | Ann Endocrinol (Paris) | 2025 | 39818300 | PubTator, text mining | PubMed |
| Genotype-Phenotype Correlations in the Hyperparathyroidism-Jaw Tumor Syndrome. | J Clin Endocrinol Metab | 2025 | 39775826 | PubTator, text mining | PubMed |
| The Delicate Balancing of Pros and Cons in the Surgical Management of Hyperparathyroidism in a Young Female with Germline Variant in the CDC73 Gene. | Calcif Tissue Int | 2025 | 39751933 | PubTator, text mining | PubMed |
| A Software Tool for Rapid and Automated Preprocessing of Large-Scale Serum Metabolomic Data by Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry. | Anal Chem | 2025 | 39729551 | PubTator, text mining | PubMed |
| CDC73 c.1155-3A>G is a pathogenic variant that causes aberrant splicing, disrupted parafibromin expression, and hyperparathyroidism-jaw tumor syndrome. | JBMR Plus | 2025 | 39677927 | PubTator, text mining | PubMed |
| Deciphering the cleavage sites of 3C-like protease in Gammacoronaviruses and Deltacoronaviruses. | Biochim Biophys Acta Proteins Proteom | 2025 | 39454742 | PubTator, text mining | PubMed |
| A Comparative Genomic Analysis of Parathyroid Adenomas and Carcinomas Harboring Heterozygous Germline CDC73 Mutations. | J Clin Endocrinol Metab | 2025 | 39044678 | PubTator, text mining | PubMed |
| A Case of Osteitis Fibrosa Cystica of the Mandible: A Rare Presentation during Pregnancy due to CDC73 Mutation. | J ASEAN Fed Endocr Soc | 2024 | 39620181 | PubTator, text mining | PubMed |
| A Case Report of an Osteolytic Mass Hiding Behind an Undiagnosed Parathyroid Adenoma. | Cureus | 2024 | 39618747 | PubTator, text mining | PubMed |
| Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors. | Cancers (Basel) | 2024 | 39594770 | PubTator, text mining | PubMed |
| Stress-Induced Evolution of the Nucleolus: The Role of Ribosomal Intergenic Spacer (rIGS) Transcripts. | Biomolecules | 2024 | 39456266 | PubTator, text mining | PubMed |
| Heterogeneous Transcriptional Landscapes in Human Sporadic Parathyroid Gland Tumors. | Int J Mol Sci | 2024 | 39409111 | PubTator, text mining | PubMed |
| Exploring mutations: GNAS and CDC73 in jaw fibroosseous lesions. | Pathol Res Pract | 2024 | 39357190 | PubTator, text mining | PubMed |
| Whole genome sequencing reveals the mutational landscape from disease diagnosis to relapse in patients with childhood acute myeloid leukaemia. | Malays J Pathol | 2024 | 39207003 | PubTator, text mining | PubMed |
| Lymphatic and blood vessels in parathyroid tumors: Immunohistochemical study with LYVE-1 and von Willebrand factor. | Biomol Biomed | 2024 | 39186016 | PubTator, text mining | PubMed |
| Combination approach for CDC73-related parathyroid carcinoma in an adolescent female patient: a case report and literature review. | Ther Adv Med Oncol | 2024 | 39099848 | PubTator, text mining | PubMed |
| [The role of immunohistochemical examination in the differential diagnosis of atypical tumors and carcinomas of parathyroid glands]. | Arkh Patol | 2024 | 39073536 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79577/papers?page=5